We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
4076
Novartis
NVS
$297B
$36K ﹤0.01%
415
+10
+2% +$866
TK icon
4077
Teekay
TK
$1.02B
$36K ﹤0.01%
11,320
-73,027
-87% -$236K
AAGRW
4078
DELISTED
African Agriculture Holdings Inc Warrant
AAGRW
$36K ﹤0.01%
+39,273
New +$45.6K
CEI
4079
DELISTED
Camber Energy, Inc
CEI
$36K ﹤0.01%
+840
New +$30.8K
IMUX icon
4080
Immunic
IMUX
$190M
$35K ﹤0.01%
304
-1,968
-87% -$228K
KOPN icon
4081
Kopin
KOPN
$663M
$35K ﹤0.01%
13,856
-80,343
-85% -$231K
RXST icon
4082
RxSight
RXST
$250M
$35K ﹤0.01%
+2,852
New +$34.2K
SPRO icon
4083
Spero Therapeutics
SPRO
$68.9M
$35K ﹤0.01%
3,930
-25,441
-87% -$261K
VKTX icon
4084
Viking Therapeutics
VKTX
$3.77B
$35K ﹤0.01%
11,430
-71,602
-86% -$257K
ML
4085
DELISTED
MoneyLion Inc.
ML
$35K ﹤0.01%
+461
New +$36K
WEBR
4086
DELISTED
Weber Inc.
WEBR
$35K ﹤0.01%
+3,523
New +$37.9K
ACVA icon
4087
ACV Auctions
ACVA
$1.29B
$34K ﹤0.01%
+2,280
New +$31.7K
AMSC icon
4088
American Superconductor
AMSC
$1.44B
$34K ﹤0.01%
4,488
-29,037
-87% -$249K
CRMD icon
4089
CorMedix
CRMD
$585M
$34K ﹤0.01%
6,154
-39,842
-87% -$182K
GXC icon
4090
State Street SPDR S&P China ETF
GXC
$460M
$34K ﹤0.01%
389
OLMA icon
4091
Olema Pharmaceuticals
OLMA
$1.02B
$34K ﹤0.01%
+8,040
New +$44.3K
RCEL icon
4092
Avita Medical
RCEL
$134M
$34K ﹤0.01%
+3,944
New +$36.4K
SGC icon
4093
Superior Group of Companies
SGC
$188M
$34K ﹤0.01%
1,907
-12,345
-87% -$245K
SGLY icon
4094
Singularity Future Technology
SGLY
$4.28M
$34K ﹤0.01%
+17
New +$16K
VLGEA icon
4095
Village Super Market
VLGEA
$651M
$34K ﹤0.01%
1,384
-8,948
-87% -$207K
WLKP icon
4096
Westlake Chemical Partners
WLKP
$763M
$34K ﹤0.01%
1,238
+1,172
+1,776% +$31.1K
INFI
4097
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$34K ﹤0.01%
28,931
-92,037
-76% -$110K
SPPI
4098
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$34K ﹤0.01%
26,470
-186,515
-88% -$172K
BSGAR
4099
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$34K ﹤0.01%
+69,836
New +$34.7K
CINC
4100
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$34K ﹤0.01%
+1,884
New +$38.7K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.